838
Views
22
CrossRef citations to date
0
Altmetric
Review

The potential role of cannabinoids in epilepsy treatment

, , , , , & show all
Pages 1069-1079 | Received 22 Jun 2017, Accepted 25 Aug 2017, Published online: 04 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Qingjun Cao, Fenghua Yang & Hua Wang. (2021) CB2R induces a protective response against epileptic seizures through ERK and p38 signaling pathways. International Journal of Neuroscience 131:8, pages 735-744.
Read now
Alessandra Morano, Martina Fanella, Mariarita Albini, Pierangelo Cifelli, Eleonora Palma, Anna Teresa Giallonardo & Carlo Di Bonaventura. (2020) Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects. Neuropsychiatric Disease and Treatment 16, pages 381-396.
Read now
Roberta Roberti, Caterina Palleria, Valentina Nesci, Martina Tallarico, Carlo Di Bonaventura, Emanuele Cerulli Irelli, Alessandra Morano, Giovambattista De Sarro, Emilio Russo & Rita Citraro. (2020) Pharmacokinetic considerations about antiseizure medications in the elderly. Expert Opinion on Drug Metabolism & Toxicology 16:10, pages 983-995.
Read now
Alessandra Morano, Luigi Iannone, Caterina Palleria, Martina Fanella, Anna Teresa Giallonardo, Giovambattista De Sarro, Emilio Russo & Carlo Di Bonaventura. (2019) Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy. Expert Opinion on Pharmacotherapy 20:1, pages 25-39.
Read now
Marco Greco, Gaia Varriale, Giangennaro Coppola, Francesca Operto, Alberto Verrotti & Maria Laura Iezzi. (2018) Investigational small molecules in phase II clinical trials for the treatment of epilepsy. Expert Opinion on Investigational Drugs 27:12, pages 971-979.
Read now

Articles from other publishers (17)

Romina Provenzano, Carmen De Caro, Antonella Vitiello, Luana Izzo, Alberto Ritieni, Francesca Ungaro, Fabiana Quaglia, Emilio Russo, Agnese Miro & Ivana d’Angelo. (2023) Enhancing transmucosal delivery of CBD through nanoemulsion: in vitro and in vivo studies. Drug Delivery and Translational Research.
Crossref
Hugo-Henrique Silva, Valéria Tavares, Beatriz Neto, Fátima Cerqueira, Rui Medeiros & Maria-Raquel Silva. (2023) FAAH rs324420 Polymorphism: Biological Pathways, Impact on Elite Athletic Performance and Insights for Sport Medicine. Genes 14:10, pages 1946.
Crossref
Leila Hosseinzadeh Anvar, Asghar Alejafar, Seyyed Ebrahim Moosavi, Saeid Charsouei, Narges Zeynalzadeh, Leila Mehdizadeh Fanid, Babak Emamalizadeh, Zahra Hassanpour Aydinlou, Helaleh Vaezi, Adel Kashefi, Carlos Tomaz, Masoud Nikanfar & Ali Ahmadalipour. (2023) The study of rs324420 (C385A) polymorphism of the FAAH gene of the endocannabinoid system in patients with epilepsy and ADHD. Epilepsy Research 192, pages 107100.
Crossref
Rosario Licitra, Maria Marchese, Valentina Naef, Asahi Ogi, Marco Martinelli, Claudia Kiferle, Baldassare Fronte & Filippo Maria Santorelli. (2022) A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment. Biomedicines 10:8, pages 1820.
Crossref
Nathan A. Shlobin, Justin M. Campbell, Joshua M. Rosenow & John D. Rolston. (2022) Ethical considerations in the surgical and neuromodulatory treatment of epilepsy. Epilepsy & Behavior 127, pages 108524.
Crossref
Daniel Zhou, Erin Dennis, Isha Snehal & Arun Swaminathan. (2021) Cannabinoids in the Treatment of Epilepsy: A Review. European Medical Journal.
Crossref
Xiaoyu Ji, Yang Zeng & Jie Wu. (2021) The CB2 Receptor as a Novel Therapeutic Target for Epilepsy Treatment. International Journal of Molecular Sciences 22:16, pages 8961.
Crossref
Qing Xin, Fei Xu, Devin H. Taylor, Jing-fu Zhao & Jie Wu. (2020) The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders. Acta Pharmacologica Sinica 41:12, pages 1507-1518.
Crossref
Sara Dubois, Francesca Marchese, Federica Pigliasco, Sebastiano Barco, Gino Tripodi, Tommaso Lomonaco, Simona Lattanzi, Emilio Russo, Giuliana Cangemi & Pasquale Striano. (2020) A Volumetric Absorptive Microsampling Technique to Monitor Cannabidiol Levels in Epilepsy Patients. Frontiers in Pharmacology 11.
Crossref
Federica Pigliasco, Sebastiano Barco, Sara Dubois, Francesca Marchese, Pasquale Striano, Tommaso Lomonaco, Francesca Mattioli, Gino Tripodi & Giuliana Cangemi. (2020) Cannabidiol Determination on Peripheral Capillary Blood Using a Microsampling Method and Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry with On-Line Sample Preparation. Molecules 25:16, pages 3608.
Crossref
J. Helen Cross & Hannah Cock. (2020) A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?. Neuropharmacology 170, pages 107861.
Crossref
Simona Lattanzi, Eugen Trinka, Pasquale Striano & Francesco Brigo. (2020) Cannabidiol Oral Solution – A New Class of Antiseizure Medication. European Neurological Review 15:1, pages 19.
Crossref
Mikail Kraft, Ara Hall & Uttam Garg. 2020. Toxicology Cases for the Clinical and Forensic Laboratory. Toxicology Cases for the Clinical and Forensic Laboratory 187 189 .
Carmen De Caro, Luigi Francesco Iannone, Rita Citraro, Pasquale Striano, Giovambattista De Sarro, Andrew Constanti, John F. Cryan & Emilio Russo. (2019) Can we ‘seize’ the gut microbiota to treat epilepsy?. Neuroscience & Biobehavioral Reviews 107, pages 750-764.
Crossref
Rui Rodrigues, Diogo Lourenço, Sara Paulo, Joana Mateus, Miguel Ferreira, Francisco Mouro, João Moreira, Filipa Ribeiro, Ana Sebastião & Sara Xapelli. (2019) Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology. Molecules 24:7, pages 1350.
Crossref
Eric P. Baron. (2018) Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. Headache: The Journal of Head and Face Pain 58:7, pages 1139-1186.
Crossref
A. V. Lebedeva, A. S. Avedisova, G. V. Kustov, A. G. Gersamiya, I. L. Kaymovskiy, F. K. Rider, I. S. Trifonov, E. V. Pashnin, E. A. Malkhasyan, A. B. Guekht & V. V. Krylov. (2018) Prognosis for surgical treatment of pharmacoresistant epilepsy: the role of mental and cognitive disorders. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:10, pages 27.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.